How are Imipramine adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Imipramine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Imipramine is flagged as the suspect drug causing the adverse event.
What are the most common Imipramine adverse events reported to the FDA?
Completed Suicide | 106 (2.24%) |
Headache | 59 (1.25%) |
Suicide Attempt | 54 (1.14%) |
Drug Exposure During Pregnancy | 53 (1.12%) |
Overdose | 52 (1.1%) |
Anxiety | 51 (1.08%) |
Depression | 51 (1.08%) |
Somnolence | 51 (1.08%) |
Drug Interaction | 47 (.99%) |
Tremor | 46 (.97%) |
Insomnia | 45 (.95%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Imipramine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Imipramine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Imipramine adverse events reported to the FDA?
Neurological | 374 (7.9%) |
Cardiac Arrhythmias | 205 (4.33%) |
Suicidal And Self-injurious Behavio... | 183 (3.87%) |
Cardiac And Vascular Investigations | 155 (3.28%) |
Medication Errors | 125 (2.64%) |
Gastrointestinal Signs | 124 (2.62%) |
Anxiety Disorders | 121 (2.56%) |
Chemical Injury And Poisoning | 118 (2.49%) |
Therapeutic And Nontherapeutic Effe... | 117 (2.47%) |
Respiratory | 114 (2.41%) |
Movement Disorders | 102 (2.16%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Imipramine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Imipramine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Imipramine, according to those reporting adverse events to the FDA?
Depression | 431 |
Drug Use For Unknown Indication | 109 |
Product Used For Unknown Indication | 94 |
Anxiety | 63 |
Enuresis | 22 |
Urinary Incontinence | 19 |
Show More |
Label | Labeler | Effective |
---|---|---|
Imipramine Hydrochloride | Bryant Ranch Prepack | 05-JUN-90 |
Imipramine Pamoate | MALLINCKRODT INC | 13-MAY-09 |
Tofranil | Mallinckrodt, Inc. | 09-SEP-09 |
Imipramine Pamoate | Roxane Laboratories, Inc | 16-APR-10 |
Imipramine Hydrochloride | LUPIN PHARMACEUTICALS INC | 12-APR-11 |
Imipramine Pamoate | LUPIN PHARMACEUTICALS INC | 13-APR-11 |
Imipramine Hydrochloride | REMEDYREPACK INC. | 21-APR-11 |
Imipramine Pamoate | STAT RX USA LLC | 25-AUG-11 |
Imipramine Hydrochloride | REMEDYREPACK INC. | 20-SEP-11 |
Imipramine Hydrochloride | REMEDYREPACK INC. | 21-SEP-11 |
Imipramine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | 13-OCT-11 |
Imipramine Hydrochloride | Sandoz Inc | 13-OCT-11 |
Imipramine Hydrochloride | Par Pharmaceutical Inc. | 22-NOV-11 |
Imipramine Hydrochloride | Golden State Medical Supply, Inc. | 09-JAN-12 |
Imipramine Hydrochloride | Richmond Pharmaceuticals, Inc. | 27-FEB-12 |
Imipramine Hydrochloride | Mutual Pharmaceutical Company, Inc. | 02-MAR-12 |
Imipramine Hydrochloride | KAISER FOUNDATION HOSPITALS | 31-MAY-12 |
Imipramine Hydrochloride | Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC | 11-JUN-12 |
Imipramine Hydrochloride | Physicians Total Care, Inc. | 01-OCT-12 |
Tofranil-pm | Mallinckrodt, Inc. | 01-OCT-12 |
Imipramine Hydrochloride | Excellium Pharmaceutical, Inc | 26-OCT-12 |
What Imipramine safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Imipramine. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Imipramine.